348 related articles for article (PubMed ID: 28324011)
1. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
[TBL] [Abstract][Full Text] [Related]
2. Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes.
Hecht R; Li YS; Sun J; Belouski E; Hall M; Hager T; Yie J; Wang W; Winters D; Smith S; Spahr C; Tam LT; Shen Z; Stanislaus S; Chinookoswong N; Lau Y; Sickmier A; Michaels ML; Boone T; Véniant MM; Xu J
PLoS One; 2012; 7(11):e49345. PubMed ID: 23209571
[TBL] [Abstract][Full Text] [Related]
3. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
[TBL] [Abstract][Full Text] [Related]
4. A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis.
Pan Q; Lin S; Li Y; Liu L; Li X; Gao X; Yan J; Gu B; Chen X; Li W; Tang X; Chen C; Guo L
EBioMedicine; 2021 Jan; 63():103202. PubMed ID: 33421947
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to improve the function of FGF21.
Smith R; Duguay A; Weiszmann J; Stanislaus S; Belouski E; Cai L; Yie J; Xu J; Gupte J; Wu X; Li Y
BioDrugs; 2013 Apr; 27(2):159-66. PubMed ID: 23456652
[TBL] [Abstract][Full Text] [Related]
6. FGF21 can be mimicked in vitro and in vivo by a novel anti-FGFR1c/β-Klotho bispecific protein.
Smith R; Duguay A; Bakker A; Li P; Weiszmann J; Thomas MR; Alba BM; Wu X; Gupte J; Yang L; Stevens J; Hamburger A; Smith S; Chen J; Komorowski R; Moore KW; Véniant MM; Li Y
PLoS One; 2013; 8(4):e61432. PubMed ID: 23630589
[TBL] [Abstract][Full Text] [Related]
7. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
8. [Expression and pharmacological evaluation of fusion protein FGF21-L-Fc].
Yao WB; Ren GP; Han Y; Cao HW; Gao HM; Kan FM; Wang Q; Li DS
Yao Xue Xue Bao; 2011 Jul; 46(7):787-92. PubMed ID: 22010347
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic investigation of the preclinical pharmacokinetics and interspecies scaling of PF-05231023, a fibroblast growth factor 21-antibody protein conjugate.
Giragossian C; Vage C; Li J; Pelletier K; Piché-Nicholas N; Rajadhyaksha M; Liras J; Logan A; Calle RA; Weng Y
Drug Metab Dispos; 2015 Jun; 43(6):803-11. PubMed ID: 25805881
[TBL] [Abstract][Full Text] [Related]
11. Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing.
Weng Y; Ishino T; Sievers A; Talukdar S; Chabot JR; Tam A; Duan W; Kerns K; Sousa E; He T; Logan A; Lee D; Li D; Zhou Y; Bernardo B; Joyce A; Kavosi M; O'Hara DM; Clark T; Guo J; Giragossian C; Stahl M; Calle RA; Kriz R; Somers W; Lin L
Sci Rep; 2018 Mar; 8(1):4241. PubMed ID: 29523796
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
Dunshee DR; Bainbridge TW; Kljavin NM; Zavala-Solorio J; Schroeder AC; Chan R; Corpuz R; Wong M; Zhou W; Deshmukh G; Ly J; Sutherlin DP; Ernst JA; Sonoda J
J Biol Chem; 2016 Mar; 291(11):5986-5996. PubMed ID: 26797127
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bioactivity and stability of a long-acting FGF21: A novel variant for the treatment of NASH.
Ji Y; Lu Q; Duan Y; Chen X; Zhang Y; Yao W; Yin J; Gao X
Biochimie; 2024 May; 225():26-39. PubMed ID: 38740172
[TBL] [Abstract][Full Text] [Related]
14. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.
Véniant MM; Sivits G; Helmering J; Komorowski R; Lee J; Fan W; Moyer C; Lloyd DJ
Cell Metab; 2015 May; 21(5):731-8. PubMed ID: 25955208
[TBL] [Abstract][Full Text] [Related]
16. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
17. NRG1-Fc improves metabolic health via dual hepatic and central action.
Zhang P; Kuang H; He Y; Idiga SO; Li S; Chen Z; Yang Z; Cai X; Zhang K; Potthoff MJ; Xu Y; Lin JD
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515030
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
19. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
20. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions.
Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z
J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
